{name}
{subtitle}
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
city
~5 mi. (Brookfield, Wisconsin, +454 more cities)
facility
Ascension Southeast Wisconsin Hospital - Elmbrook Campus
drug
brentuximab vedotin, +7 more drugs
drug type
chemotherapy, +3 more types
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~5 mi. (Brookfield, Wisconsin, +825 more cities)
facility
Ascension Southeast Wisconsin Hospital - Elmbrook Campus
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
city
~5 mi. (Brookfield, Wisconsin, +822 more cities)
facility
Wheaton Franciscan Healthcare-Elmbrook Memorial Hospital
biomarker
ER Negative, +2 more biomarkers
drug
carboplatin, +3 more drugs
Testing The Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia
city
~5 mi. (Brookfield, Wisconsin, +556 more cities)
facility
Ascension Southeast Wisconsin Hospital - Elmbrook Campus
biomarker
CD19 Expression, +2 more biomarkers
drug
ibrutinib, +2 more drugs
drug type
chemotherapy, +2 more types